Average Co-Inventor Count = 1.61
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ventus Therapeutics U.s., Inc. (12 from 12 patents)
2. Repare Therapeutics Inc. (1 from 2 patents)
13 patents:
1. 12441728 - Pyridazine compounds for inhibiting NLRP3
2. 12410167 - Pyridazine compounds for inhibiting NLRP3
3. 12398136 - Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
4. 12351578 - Compounds for inhibiting NLRP3 and uses thereof
5. 12331048 - Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
6. 12312350 - Compounds for inhibiting NLRP3 and uses thereof
7. 12312351 - Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
8. 12281112 - Compounds for inhibiting NLRP3 and uses thereof
9. 12264155 - Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as ATR kinase inhibitors
10. 12195460 - Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
11. 12168657 - Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
12. 11618751 - Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
13. 11319319 - Compounds for inhibiting NLRP3 and uses thereof